Clinical Trials Logo

Clinical Trial Summary

This study will evaluate the impact of a program (called mind. body. voice. or "mbv") that was collaboratively designed by youth, educators, and researchers, informed by the Body Project (Becker et al., 2013; Stice et al., 2019), Youth Participatory Action Research, and an extended co-design process. The study evaluates the impact of the mbv program on key aspects of mental health and well-being; specifically, body image and disordered eating symptoms, identity and agency, social and self-constructs, physical health and mood at five time points over the course of a year. Students will be recruited from two high schools and will be randomized to receive the mbv program or an assessment-only control group.


Clinical Trial Description

Eating disorders have the highest mortality rate of any psychiatric condition and are the second leading cause of mental health disability among young women. Given that eating disorders have their peak onset during adolescence (ages 16-19), prevention efforts among adolescent women are critical in order to avert the onset of these chronic and disabling disorders. The mbv program targets body image and appearance related pressures, awareness of body sensations, and agency and community building skills.The program consists of 10 weekly sessions and is delivered by peer facilitators. This study will implement and evaluate the mbv program at the high school level in order to examine the extent to which the program influences young women's mental health and well-being, particularly related to eating disorder risk factors and symptoms. Utilizing a longitudinal randomized controlled trial, the study seeks to address the following aims: 1. To examine the impact of the mbv program on key aspects of mental health and well-being; specifically, body image and disordered eating symptoms, identity and agency, social and self- constructs, physical health and mood among participating high school women. 2. To explore young women's experiences of participating in the program, including strengths and limitations and perspectives on specific activities. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04591886
Study type Interventional
Source University of Colorado, Boulder
Contact
Status Completed
Phase N/A
Start date September 1, 2019
Completion date May 31, 2021

See also
  Status Clinical Trial Phase
Completed NCT03097874 - Adaptive Treatment for Adolescent Anorexia Nervosa N/A
Completed NCT04591912 - The Peer-Delivered "Mind. Body. Voice." Program for High School Women (Mbv) - Remote N/A
Recruiting NCT06431854 - Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program N/A
Completed NCT05554458 - Implementation and Evaluation of the ChildTaks+ Intervention in the Czech Republic N/A
Recruiting NCT04552639 - Evaluation of Compulsive Exercise Group Therapy for Eating Disorders N/A
Completed NCT05091983 - Restrictive Eating Disorders: From Childhood Orality Disorder to Adolescent Dysensoriality
Active, not recruiting NCT04127214 - The ITA Model of Integrated Treatment of Eating Disorders
Completed NCT04888273 - Assessing the Feasibility of an Intervention for Youth and Parents Transitioning to Adult Eating Disorder Services N/A
Recruiting NCT03563755 - Social Information Processing in Adolescents With Eating Disorders N/A
Active, not recruiting NCT05780242 - Recrudescence of Eating Conduct Disorders and Covid-19
Active, not recruiting NCT03693911 - ACT to Prevent Eating Disorders: Evaluating a Gamified Prevention Program N/A
Recruiting NCT03855553 - Project CORE: Disseminating Eating Disorders Treatment Phase 1
Completed NCT04088097 - Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating N/A
Completed NCT04263155 - The Peer-Delivered Body Project for Young Women in High School N/A
Completed NCT06039514 - Mobile App for Eating Disorders in Adolescents N/A
Enrolling by invitation NCT04869423 - Animal-Assisted Therapy in Adolescents With Eating Disorders N/A
Terminated NCT05073679 - Oral Naltrexone In Pediatric Eating Disorders Phase 2/Phase 3